Comparison of standardized uptake value-based positron emission tomography and computed tomography target volumes in esophageal cancer patients undergoing radiotherapy

Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1057-63. doi: 10.1016/j.ijrobp.2009.09.022. Epub 2010 Mar 2.

Abstract

Purpose: To study various standardized uptake value (SUV)-based approaches to ascertain the best strategy for delineating metabolic tumor volumes (MTV).

Methods and materials: Twenty-two consecutive previously treated esophageal cancer patients with positron emission tomography (PET) imaging and computed tomography (CT)-based radiotherapy plans were studied. At the level of the tumor epicenter, MTVs were delineated at 11 different thresholds: SUV ≥2, ≥2.5, ≥3, ≥3.5 (SUV(n)); ≥40%, ≥45%, and ≥50% of the maximum (SUV(n%)); and mean liver SUV + 1, 2, 3, and 4 standard deviations (SUV(Lnσ)). The volume ratio and conformality index were determined between MTVs, and the corresponding CT/endoscopic ultrasound-based gross tumor volume (GTV) at the epicenter. Means were analyzed by one-way analysis of variance for repeated measures and further compared using a paired t test for repeated measures.

Results: The mean conformality indices ranged from 0.33 to 0.48, being significantly (p < 0.05) closest to 1 at SUV(2.5) (0.47 ± 0.03) and SUV(L4σ) (0.48 ± 0.03). The mean volume ratios ranged from 0.39 to 2.82, being significantly closest to 1 at SUV(2.5) (1.18 ± 0.36) and SUV(L4σ) (1.09 ± 0.15). The mean value of the SUVs calculated using the SUV(L4σ) approach was 2.4.

Conclusions: Regardless of the SUV thresholding method used (i.e., absolute or relative to liver mean), a threshold of approximately 2.5 yields the highest conformality index and best approximates the CT-based GTV at the epicenter. These findings may ultimately aid radiation oncologists in the delineation of the entire GTV in esophageal cancer patients.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Analysis of Variance
  • Esophageal Neoplasms / diagnostic imaging*
  • Esophageal Neoplasms / metabolism
  • Esophageal Neoplasms / radiotherapy
  • Fluorodeoxyglucose F18 / pharmacokinetics
  • Humans
  • Liver / diagnostic imaging
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals / metabolism
  • Radiotherapy Planning, Computer-Assisted / methods
  • Retrospective Studies
  • Tomography, X-Ray Computed / methods*
  • Tumor Burden*
  • Ultrasonography, Interventional / methods

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18